Quick Answer
Werewolf Therapeutics, Inc. reported Earnings Per Share Diluted of $1.33 (loss) per share for the year ending 2025.
- Werewolf Therapeutics, Inc. showed an increase of +18.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Werewolf Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Werewolf Therapeutics, Inc.'s Earnings Per Share Diluted has grown by 95.3%.
- Historical annual values: Fiscal year 2025: $1.33 (loss) per share | Fiscal year 2024: $1.63 (loss) per share | Fiscal year 2023: $1.05 (loss) per share | Fiscal year 2022: $1.86 (loss) per share | Fiscal year 2021: $10.94 (loss) per share | Fiscal year 2020: $28.08 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: